Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited)

v3.25.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Operating expenses:    
Research and development $ 15,642 $ 5,762
General and administrative 4,133 3,861
Total operating expenses 19,775 9,623
Operating loss (19,775) (9,623)
Other income (expense), net:    
Interest and investment income, net 1,681 1,028
Interest expense 0 (839)
Other income, net 1,116 2,535
Total other income, net 2,797 2,724
Net loss $ (16,978) $ (6,899)
Net loss per share of common stock-basic $ (1.39) $ (0.83)
Net loss per share of common stock-diluted $ (1.39) $ (0.83)
Weighted average number of common shares outstanding, basic 12,202,092 8,310,508
Weighted average number of common shares outstanding, diluted 12,202,092 8,310,508
Comprehensive loss:    
Net Income (Loss) $ (16,978) $ (6,899)
Other comprehensive loss:    
Change in unrealized (loss) gain on marketable debt securities (58) (328)
Total other comprehensive (loss) income (58) (328)
Total comprehensive loss $ (17,036) $ (7,227)